Huawei moves from blood-pressure watches to a continuous glucose monitor

Huawei's wearable business has been drifting toward medical claims for a while — blood-pressure monitoring on watches was the last big step. The next one is bigger: HUAWEI Sence G1, the company's first continuous glucose monitor and its first Class III medical device.

What the device does

The Sence G1 measures glucose continuously and pushes the readings to Huawei's own ecosystem: a phone, a smartwatch, or a fitness band. Continuous monitoring is a different product from a fingerstick test — instead of a single number taken a few times a day, you get a curve, which is what makes trends and post-meal spikes visible at all.

That ecosystem dependency cuts both ways. It is why the experience can be tight on Huawei hardware, and it is why the product is unlikely to appear in markets where Huawei's phone and wearable sales have been squeezed.

The detail that is missing

Huawei announced the G1 in a Weibo post and stopped short of the numbers that decide whether a CGM is practical: price, availability, and how long a sensor lasts before it needs replacing. Sensor life is the single most important spec in this category — a two-week sensor and a one-week sensor are different products at the same price.

Huawei VP Bruce Lee said the product had been in development for roughly three years, describing it as one of the hardest things the company has had to master. The long gap to launch is at least partly regulatory: China's National Medical Products Administration approved the device on 30 October, per VCBeat.

Why this is a bigger deal than one product

A CGM is a regulated medical device, not a wellness gimmick. Shipping one means Huawei has built the clinical validation pipeline, not just the sensor. That is a moat competitors cannot copy with a firmware update, and it points at where wearables are heading generally: from step counts and heart rate toward measurements that a doctor would recognise.

For most readers, the practical takeaway is a reminder to read wearable health claims carefully. Blood pressure, SpO2 and glucose features vary enormously in accuracy between brands and price points, and the regulated ones are usually labelled as such. A watch that estimates is not a device that measures.

Source: Android Authority — HUAWEI reveals its first continuous glucose monitor